Regulation (EU) 2019/933 of the European Parliament and of the Council of 20 May 2019 amending Regulation (EC) No 469/2009 concerning the supplementary protection certificate for medicinal products
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
XVII Intellectual Property
Joint committee decision (JCD)
197/2022 In force in the EEA
Yes Legal documents
Regulation (EU) 2019/933 of the European Parliament and of the Council of 20 May 2019 amending Regulation (EC) No 469/2009 concerning the supplementary protection certificate for medicinal products
Reglugerð Evrópuþingsins og ráðsins (ESB) 2019/933 frá 20. maí 2019 um breytingu á reglugerð (EB) nr. 469/2009 um vottorð um viðbótarvernd fyrir lyf
Verordnung (EU) 2019/933 des Europäischen Parlaments und des Rates vom 20. Mai 2019 zur Änderung der Verordnung (EG) Nr. 469/2009 über das ergänzende Schutzzertifikat für Arzneimittel
History
01.02.2023
Adopted JCD confirmed entry into force date
01.02.2023
Compliance date in the EEA
20.12.2022
Constitutional requirements under Art. 103 fulfillment date (NO)
Norway
10.06.2022
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
30.03.2022
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
20.05.2019
Adoption date in the EU
01.07.2019
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.